Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕Zerodha CASE Nifty Midcap 150 ETF · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFZerodha CASE Nifty Midcap 150 ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaZerodha
NAV₹29.1863₹11.4813
NAV date20 Nov 202620 Nov 2026
History5.4 years2.4 years
Expense ratio0.2%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFZerodha CASE Nifty Midcap 150 ETF
1 month+10.82%+5.99%
3 months+7.43%−2.49%
6 months+14.54%+1.98%
YTD+25.40%+3.27%
1 year+25.57%+2.73%
3 years (CAGR)+22.02%—
5 years (CAGR)+16.60%—
10 years (CAGR)——
Since launch+14.02%+4.83%

Risk

Nippon India Nifty Pharma ETFZerodha CASE Nifty Midcap 150 ETF
Volatility15.0%—
Downside volatility9.0%—
Sharpe1.04—
Sortino1.72—
Calmar1.33—
Return / risk1.47—
Deepest fall−20.98%−20.81%
Days to recover136257
Below its high−1.75%−3.15%

Against benchmark

Nippon India Nifty Pharma ETFZerodha CASE Nifty Midcap 150 ETF
Alpha+0.00%—
Beta1.00—
R²100.0%—
Up capture100.0%—
Down capture100.0%—
Tracking error0.0%—
Information ratio——
Treynor0.14—

Consistency

Nippon India Nifty Pharma ETFZerodha CASE Nifty Midcap 150 ETF
Best 1-year+65.21%+22.29%
Middle 1-year+13.46%+6.15%
Worst 1-year−15.30%−5.36%
1-year periods with a loss25.8%13.3%
Middle 3-year+20.51%—
Positive months61.1%—
Best day+3.64%+3.97%
Worst day−4.03%−3.92%
Worst 5% day−1.62%−2.04%
Positive days54.4%55.2%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFZerodha CASE Nifty Midcap 150 ETF
5-year XIRR+20.60%—
5-year value₹10,11,738—
3-year XIRR+19.58%—
1-year XIRR+34.31%+6.80%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth